Literature DB >> 19596119

The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.

Manabu Kawai1, Masaji Tani, Yasuhito Kobayashi, Takeshi Tsuji, Katsuyoshi Tabuse, Tetsuya Horiuchi, Masami Oka, Kazuya Yamaguchi, Yoshifumi Sakata, Tomoo Shimomura, Hiroki Yamaue.   

Abstract

BACKGROUND: The lymph node ratio, defined as the ratio between the number of lymph node metastasis and the total number of lymph nodes examined, has been reported to be an important prognostic factor in other gastrointestinal carcinomas except middle and distal bile duct carcinomas.
METHODS: Between 1991 and 2004, 62 consecutive patients who underwent surgery for middle and distal bile duct carcinoma were retrospectively analyzed concerning prognostic factors.
RESULTS: The median number of lymph nodes examined was 12 (range 5 to 38). The overall 5-year survival rates of patients with lymph node ratio of 0, lymph node ratio of 0 to .2, and lymph node ratio >.2 were 62%, 41%, and 0%, respectively. A multivariate analysis revealed that a lymph node ratio >.2 and perineural invasion were independent predictive factors for survival.
CONCLUSIONS: Lymph node ratio >.2 is an important factor to predict survival after resected middle and distal bile duct carcinoma. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19596119     DOI: 10.1016/j.amjsurg.2009.01.019

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

1.  Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Authors:  Jian-Wei Zhang; Yun-Mian Chu; Zhong-Min Lan; Xiao-Long Tang; Ying-Tai Chen; Cheng-Feng Wang; Xu Che
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.

Authors:  Stefano Andrianello; Salvatore Paiella; Valentina Allegrini; Marco Ramera; Alessandra Pulvirenti; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2015-07-02       Impact factor: 3.445

3.  Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio?

Authors:  Sanjay Singh Negi; Amanjeet Singh; Adarsh Chaudhary
Journal:  J Gastrointest Surg       Date:  2011-04-13       Impact factor: 3.452

4.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

5.  Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach.

Authors:  Kyueng-Whan Min; Dong-Hoon Kim; Byoung Kwan Son; Eun-Kyung Kim; Sang Bong Ahn; Seong Hwan Kim; Yun Ju Jo; Young Sook Park; Jinwon Seo; Young Ha Oh; Sukjoong Oh; Ho Young Kim; Mi Jung Kwon; Soo Kee Min; Hye-Rim Park; Ji-Young Choe; Jang Yong Jeon; Hong Il Ha; Jung Woo Lee
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 6.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18

7.  Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer.

Authors:  Takehiro Noji; Masaki Miyamoto; Kanako C Kubota; Toshiya Shinohara; Yoshiyasu Ambo; Yoshihiro Matsuno; Nobuichi Kashimura; Satoshi Hirano
Journal:  World J Surg Oncol       Date:  2012-06-08       Impact factor: 2.754

8.  Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma.

Authors:  Johannes Byrling; Roland Andersson; Agata Sasor; Gert Lindell; Daniel Ansari; Johan Nilsson; Bodil Andersson
Journal:  Ann Gastroenterol       Date:  2017-06-20

9.  Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma.

Authors:  Tatsuo Shimura; Yasuhide Kofunato; Ryo Okada; Rei Yashima; Yoshihisa Koyama; Kenichiro Araki; Hiroyuki Kuwano; Seiichi Takenoshita
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

10.  Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas.

Authors:  Hua-Peng Lin; Sheng-Wei Li; Ye Liu; Shi-Ji Zhou
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.